These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1360195

  • 41. Cholinergic deficits contribute to behavioral disturbance in patients with dementia.
    Minger SL, Esiri MM, McDonald B, Keene J, Carter J, Hope T, Francis PT.
    Neurology; 2000 Nov 28; 55(10):1460-7. PubMed ID: 11094098
    [Abstract] [Full Text] [Related]

  • 42. Muscarinic receptor compensation in hippocampus of Alzheimer patients.
    Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B.
    J Neural Transm; 1983 Nov 28; 56(1):13-9. PubMed ID: 6133910
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
    Rinne JO, Säkö E, Paljärvi L, Mölsä PK, Rinne UK.
    J Neural Transm; 1988 Nov 28; 73(2):121-8. PubMed ID: 3210004
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Bilateral symmetry of cholinergic deficits in Alzheimer's disease.
    Zubenko GS, Moossy J, Hanin I, Martinez AJ, Rao GR, Kopp U.
    Arch Neurol; 1988 Mar 28; 45(3):255-9. PubMed ID: 3341949
    [Abstract] [Full Text] [Related]

  • 50. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease.
    Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ.
    Arch Neurol; 1999 Dec 28; 56(12):1458-61. PubMed ID: 10593300
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Convergent cholinergic activities in aging and Alzheimer's disease.
    Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH.
    Neurobiol Aging; 1992 Dec 28; 13(3):393-400. PubMed ID: 1625768
    [Abstract] [Full Text] [Related]

  • 56. Degeneration of the cholinergic innervation of the locus ceruleus in Alzheimer's disease.
    Strong R, Huang JS, Huang SS, Chung HD, Hale C, Burke WJ.
    Brain Res; 1991 Feb 22; 542(1):23-8. PubMed ID: 2054656
    [Abstract] [Full Text] [Related]

  • 57. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.
    Hansen LA, DeTeresa R, Davies P, Terry RD.
    Neurology; 1988 Jan 22; 38(1):48-54. PubMed ID: 3336463
    [Abstract] [Full Text] [Related]

  • 58. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.
    Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM.
    Neurosurgery; 1984 Oct 22; 15(4):514-8. PubMed ID: 6149490
    [Abstract] [Full Text] [Related]

  • 59. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.
    McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T.
    Neurology; 1984 Jun 22; 34(6):741-5. PubMed ID: 6539435
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.